Celgene Corporation
CELGENE CORP /DE/ (Form: 4, Received: 11/04/2014 16:08:14)
FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

HUGIN ROBERT J
2. Issuer Name and Ticker or Trading Symbol

CELGENE CORP /DE/ [ CELG ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
see remarks
(Last)          (First)          (Middle)

C/O CELGENE CORPORATION, 86 MORRIS AVENUE
3. Date of Earliest Transaction (MM/DD/YYYY)

11/3/2014
(Street)

SUMMIT, NJ 07901
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   11/3/2014     M    144400   A $7.125   1169158   D    
Common Stock   11/3/2014     M    40000   A $8.5575   1209158   D    
Common Stock   11/3/2014     M    40000   A $10.3025   1249158   D    
Common Stock   11/3/2014     M    40000   A $13.3675   1289158   D    
Common Stock   11/3/2014     M    240000   A $17.0225   1529158   D    
Common Stock   11/3/2014     M    240000   A $17.835   1769158   D    
Common Stock   11/3/2014     F    433858   D $107.41   1335300   D    
Common Stock   11/3/2014     S    158000   D $106.68   (1) 1177300   D    
Common Stock                  27177   I   401(k) Plan  
Common Stock                  9600   (2) I   By Children  

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option(right to buy)   $7.125   11/3/2014     M         144400      (3) 2/15/2015   Common Stock   144400   $0.00   (4) 0   D    
Stock Option(right to buy)   $8.5575   11/3/2014     M         40000      (3) 4/5/2015   Common Stock   40000   $0.00   (4) 0   D    
Stock Option(right to buy)   $10.3025   11/3/2014     M         40000      (3) 7/5/2015   Common Stock   40000   $0.00   (4) 0   D    
Stock Option(right to buy)   $13.3675   11/3/2014     M         40000      (3) 10/4/2015   Common Stock   40000   $0.00   (4) 0   D    
Stock Option(right to buy)   $17.0225   11/3/2014     M         240000      (3) 12/29/2015   Common Stock   240000   $0.00   (4) 0   D    
Stock Option(right to buy)   $17.835   11/3/2014     M         240000      (3) 12/29/2015   Common Stock   240000   $0.00   (4) 0   D    

Explanation of Responses:
( 1)  The price reported in Column 4 is a weighted average price. These shares were sold pursuant to the reporting person's Rule 10b5-1 plan in multiple transactions at prices ranging from $106.06 to $107.49, inclusive. The reporting person undertakes to provide to Celgene Corporation (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
( 2)  The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
( 3)  The option was fully exercisable.
( 4)  The option was issued pursuant to the Celgene Corporation 2008 Stock Incentive Plan (Amended and Restated as of April 17, 2013).

Remarks:
Chairman and Chief Executive Officer

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
HUGIN ROBERT J
C/O CELGENE CORPORATION
86 MORRIS AVENUE
SUMMIT, NJ 07901
X
see remarks

Signatures
/s/Robert J Hugin_________________ Robert J Hugin 11/4/2014
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.